Literature DB >> 26075488

Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate.

Kennerly S Patrick1, Arthur B Straughn, Owen T Reeves, Hilary Bernstein, Robert Malcolm.   

Abstract

The potentiation of positive subjective responses to immediate-release dexmethylphenidate (d-MPH) or dl-methylphenidate (dl-MPH) by ethanol was investigated over the time course of maximal drug exposure after a single dose. In a 4-way, randomized, crossover study design, 12 men and 12 women normal volunteers received d-MPH (0.15 mg/kg) or dl-MPH (0.3 mg/kg) with or without ethanol (0.6 g/kg). Serial visual analog scales were used as surrogates for drug abuse liability ("high," "good," "like," "stimulated," and "any drug effect"). Combining pure d-MPH with ethanol significantly (P < 0.005) increased the area under the effect curves (AUC(0-5.25h)) of all 5 subscales. The dl-MPH-ethanol combination significantly (P < 0.05) increased these AUCs with the exception of like (P = 0.08). Effects of the pure d-MPH-ethanol combination exhibited delayed potentiation relative to dl-MPH-ethanol. A pharmacokinetic interaction between the l-isomer of dl-MPH and ethanol has previously been shown to increase early exposure to d-MPH. Administration of the pure isomer d-MPH precludes this absorption phase pharmacokinetic interaction with ethanol. This notwithstanding, the pure d-MPH-ethanol combination resulted in comparable, if not greater, cumulative stimulant potentiation than the dl-MPH-ethanol combination. These findings provide evidence of a pharmacodynamic component to d-MPH-ethanol synergistic interactions and carry implications for the rational drug individualization in the treatment of attention-deficit/hyperactivity disorder.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26075488      PMCID: PMC4485535          DOI: 10.1097/JCP.0000000000000348

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  21 in total

1.  Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.

Authors:  N D Volkow; G J Wang; J S Fowler; J Logan; S J Gatley; C Wong; R Hitzemann; N R Pappas
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

Review 2.  Serum and brain concentrations of methylphenidate: implications for use and abuse.

Authors:  J M Swanson; N D Volkow
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

3.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

4.  Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity.

Authors:  Robin L Williard; Lawrence D Middaugh; Hao-Jie B Zhu; Kennerly S Patrick
Journal:  Behav Pharmacol       Date:  2007-02       Impact factor: 2.293

5.  Dopaminergic neurons in the ventral tegmental area of C57BL/6J and DBA/2J mice differ in sensitivity to ethanol excitation.

Authors:  M S Brodie; S B Appel
Journal:  Alcohol Clin Exp Res       Date:  2000-07       Impact factor: 3.455

6.  Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.

Authors:  K S Patrick; A B Straughn; R R Minhinnett; S D Yeatts; A E Herrin; C L DeVane; R Malcolm; G C Janis; J S Markowitz
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

7.  Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.

Authors:  S J Gatley; N D Volkow; A N Gifford; J S Fowler; S L Dewey; Y S Ding; J Logan
Journal:  Psychopharmacology (Berl)       Date:  1999-09-01       Impact factor: 4.530

8.  Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.

Authors:  Christine Darredeau; Sean P Barrett; Bianca Jardin; Robert O Pihl
Journal:  Hum Psychopharmacol       Date:  2007-12       Impact factor: 1.672

9.  PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

Authors:  Thomas J Spencer; Joseph Biederman; Patrick E Ciccone; Bertha K Madras; Darin D Dougherty; Ali A Bonab; Elijahu Livni; Dolly A Parasrampuria; Alan J Fischman
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

Review 10.  Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Authors:  Kennerly S Patrick; Timothy R Corbin; Cristina E Murphy
Journal:  J Pharm Sci       Date:  2014-10-09       Impact factor: 3.534

View more
  2 in total

1.  Absorption Differences between Immediate-Release Dexmethylphenidate and dl-Methylphenidate.

Authors:  Kennerly S Patrick; Arthur B Straughn
Journal:  Drug Metab Dispos       Date:  2016-01-04       Impact factor: 3.922

2.  Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers.

Authors:  Hao-Jie Zhu; Kennerly S Patrick; Arthur B Straughn; Owen T Reeves; Hilary Bernstein; Jian Shi; Heather J Johnson; Joshua M Knight; Aaron T Smith; Robert J Malcolm; John S Markowitz
Journal:  J Clin Psychopharmacol       Date:  2017-08       Impact factor: 3.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.